Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma

被引：19

作者：

Gertz, Morie A. ^{[1
]}

Buadi, Francis K. ^{[2
]}

Hayman, Suzanne R. ^{[3
]}

Lacy, Martha Q. ^{[1
]}

Dispenzieri, Angela ^{[1
]}

Dingli, David ^{[1
]}

Gonsalves, Wilson I. ^{[1
]}

Kumar, Shaji ^{[1
]}

Kapoor, Prashant ^{[2
]}

Kourelis, Taxiarchis ^{[2
]}

Hogan, William J. ^{[2
]}

机构：

[1] Mayo Clin, Dept Med, Div Hematol, Rochester, MN USA

[2] Mayo Clin, Div Hematolgy, Rochester, MN USA

[3] Mayo Clin, Dept Med, Hematol Oncol Div, Rochester, MN USA

来源：

MAYO CLINIC PROCEEDINGS | 2018年 / 93卷 / 01期

关键词：

D O I：

10.1016/j.mayocp.2017.09.012

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Systems have been put in place in the Mayo Clinic Stem Cell Transplantation program to reduce day-100 all-cause mortality. Currently our mortality has been reduced to 0.3%. Patients can undergo transplant as an outpatient, with a median hospital duration of 0 days and only 25% of patients requiring a hospital stay of 5 days or greater. Outpatient transplantation is safe and reduces patient-incurred costs. (C) 2017 Mayo Foundation for Medical Education and Research

引用

页码：56 / 58

页数：3

共 8 条

[1] Single versus double autologous stem-cell transplantation for multiple myeloma [J].

Attal, M ;

Harousseau, JL ;

Facon, T ;

Guilhot, F ;

Doyen, C ;

Fuzibet, JG ;

Monconduit, M ;

Hulin, C ;

Caillot, D ;

Bouabdallah, R ;

Voillat, L ;

Sotto, JJ ;

Grosbois, B ;

Bataille, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (26) :2495-2502

[2] Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma [J].

Attal, Michel ;

Lauwers-Cances, Valerie ;

Hulin, Cyrille ;

Leleu, Xavier ;

Caillot, Denis ;

Escoffre, Martine ;

Arnulf, Bertrand ;

Macro, Margaret ;

Belhadj, Karim ;

Garderet, Laurent ;

Roussel, Murielle ;

Payen, Catherine ;

Mathiot, Claire ;

Fermand, Jean P. ;

Meuleman, Nathalie ;

Rollet, Sandrine ;

Maglio, Michelle E. ;

Zeytoonjian, Andrea A. ;

Weller, Edie A. ;

Munshi, Nikhil ;

Anderson, Kenneth C. ;

Richardson, Paul G. ;

Facon, Thierry ;

Avet-Loiseau, Herve ;

Harousseau, Jean-Luc ;

Moreau, Philippe .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (14) :1311-1320

[3] Transplantation related toxicity and mortality in older autologous hematopoietic cell transplantation recipients [J].

Belete, Hewan ;

Burns, Linda J. ;

Shanley, Ryan ;

Nayar, Manju ;

McClune, Brian ;

Lazaryan, Aleksandr ;

Bachanova, Veronika ;

Bejanyan, Nelli ;

Ustun, Celalettin ;

Brunstein, Claudio ;

Weisdorf, Daniel J. ;

Arora, Mukta .

AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (09) :E529-E533

[4] High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma [J].

Child, JA ;

Morgan, GJ ;

Davies, FE ;

Owen, RG ;

Bell, SE ;

Hawkins, K ;

Brown, J ;

Drayson, MT ;

Selby, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (19) :1875-1883

[5]

Gaballa MR, 2012, EXPERT REV HEMATOL, V5, P51, DOI [10.1586/EHM.11.72, 10.1586/ehm.11.72]

[6]

MCELWAIN TJ, 1983, LANCET, V2, P822

[7]

Medical education in the United States, 1969, JAMA-J AM MED ASSOC, V210, P1455

[8] In-Hospital Mortality and Post-Transplantation Complications in Elderly Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Population-Based Study [J].

Sanchez, Larysa ;

Sylvester, Michael ;

Parrondo, Ricardo ;

Mariotti, Veronica ;

Eloy, Jean Anderson ;

Chang, Victor T. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) :1203-1207

← 1 →